Cite
Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.
MLA
Rouphael, Nadine G., et al. “Immunogenicity of a 2-Dose Regimen of Moderna MRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.” Journal of Infectious Diseases, vol. 228, no. 12, Dec. 2023, pp. 1662–66. EBSCOhost, https://doi.org/10.1093/infdis/jiad323.
APA
Rouphael, N. G., Branche, A. R., Diemert, D. J., Falsey, A. R., Losada, C., Baden, L. R., Frey, S. E., Whitaker, J. A., Little, S. J., Kamidani, S., Walter, E. B., Novak, R. M., Rupp, R., Jackson, L. A., Babu, T. M., Kottkamp, A. C., Luetkemeyer, A. F., Immergluck, L. C., Presti, R. M., & Bäcker, M. (2023). Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial. Journal of Infectious Diseases, 228(12), 1662–1666. https://doi.org/10.1093/infdis/jiad323
Chicago
Rouphael, Nadine G, Angela R Branche, David J Diemert, Ann R Falsey, Cecilia Losada, Lindsey R Baden, Sharon E Frey, et al. 2023. “Immunogenicity of a 2-Dose Regimen of Moderna MRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.” Journal of Infectious Diseases 228 (12): 1662–66. doi:10.1093/infdis/jiad323.